Literature summary extracted from
Mathialagan, S.; Poda, G.I.; Kurumbail, R.G.; Selness, S.R.; Hall, T.; Reitz, B.A.; Weinberg, R.A.; Kishore, N.; Mbalaviele, G.
Expression, purification and functional characterization of IkappaB kinase-2 (IKK-2) mutants (2010), Protein Expr. Purif., 72, 254-261.
Application
EC Number |
Application |
Comment |
Organism |
---|
2.7.11.10 |
drug development |
because of its central role in the overall NF-kappaB regulation, IKK-2 is a viable target for drug discovery |
Homo sapiens |
Cloned(Commentary)
EC Number |
Cloned (Comment) |
Organism |
---|
2.7.11.10 |
expression of C-terminally FLAG-tagged wild-type and mutant IKK-2s |
Homo sapiens |
Protein Variants
EC Number |
Protein Variants |
Comment |
Organism |
---|
2.7.11.10 |
D145A |
site-directed mutagenesis, the IKK-2 is devoid of kinase activity despite its ability to bind ATP with high affinity and is not phosphorylated at the T loop. mutant binds a diverse collection of inhibitors with comparable binding affinities to wild-type IKK-2, inhibition by PHA-408 is reduced compared to the wild-type enzyme |
Homo sapiens |
2.7.11.10 |
F26A |
site-directed mutagenesis, the mutant has lost the time-dependent binding of inhibitor PHA-408 |
Homo sapiens |
2.7.11.10 |
F26W |
site-directed mutagenesis |
Homo sapiens |
2.7.11.10 |
K106N |
site-directed mutagenesis |
Homo sapiens |
2.7.11.10 |
K106Q |
site-directed mutagenesis, the mutant shows time-dependent inhibition like the wild-type, inhibition by PHA-408 is slightly increased compared to the wild-type enzyme |
Homo sapiens |
2.7.11.10 |
M96L |
site-directed mutagenesis |
Homo sapiens |
2.7.11.10 |
Y169F |
site-directed mutagenesis, the mutant shows time-dependent inhibition by PHA-408 like the wild-type |
Homo sapiens |
Inhibitors
EC Number |
Inhibitors |
Comment |
Organism |
Structure |
---|
2.7.11.10 |
1-(4-chlorophenyl)-4-ureido-1H-pyrazole-3-carboxamide |
i.e. SC-108 |
Homo sapiens |
|
2.7.11.10 |
1-(benzo[d][1,3]dioxol-5-yl)-8-(3-chloroisonicotinamido)-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide |
i.e. PHA-379 |
Homo sapiens |
|
2.7.11.10 |
1-(benzo[d][1,3]dioxol-5-yl)-8-(5-chloro-2-(4-methylpiperazin-1-yl)isonicotinamido)-4,5-dihydro-1H-benzo-[g]indazole-3-carboxamide |
i.e. PHA-250 |
Homo sapiens |
|
2.7.11.10 |
2-amino-6-(2-hydroxy-6-isobutoxyphenyl)-4-(piperidin-3-yl)nicotinonitrile |
i.e. PHA-535E |
Homo sapiens |
|
2.7.11.10 |
5-((3-fluorophenyl)ethynyl)-2-ureidothiophene-3-carboxamide |
i.e. PHA-966 |
Homo sapiens |
|
2.7.11.10 |
5-(4-fluorophenyl)-2-ureidothiophene-3-carboxamide |
i.e. SC-440 |
Homo sapiens |
|
2.7.11.10 |
5-amino-2,30-bithiophene-4-carboxamide |
i.e. SC-514 |
Homo sapiens |
|
2.7.11.10 |
additional information |
structure-based design of IKK-2 inhibitors based on induced-fit docking into the homology model, overview |
Homo sapiens |
|
2.7.11.10 |
N1-(1,8-dimethylimidazo-[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine |
i.e. PHA-068E |
Homo sapiens |
|
2.7.11.10 |
PHA-408 |
a selective IKK-2 inhibitor, shows time-dependent binding to the enzyme |
Homo sapiens |
|
Metals/Ions
EC Number |
Metals/Ions |
Comment |
Organism |
Structure |
---|
2.7.11.10 |
Mg2+ |
required |
Homo sapiens |
|
Natural Substrates/ Products (Substrates)
EC Number |
Natural Substrates |
Organism |
Comment (Nat. Sub.) |
Natural Products |
Comment (Nat. Pro.) |
Rev. |
Reac. |
---|
2.7.11.10 |
ATP + [IkappaB protein] |
Homo sapiens |
- |
ADP + [IkappaB phosphoprotein] |
- |
? |
|
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
2.7.11.10 |
Homo sapiens |
O14920 |
- |
- |
Purification (Commentary)
EC Number |
Purification (Comment) |
Organism |
---|
2.7.11.10 |
recombinant C-terminally FLAG-tagged wild-type and mutant IKK-2s |
Homo sapiens |
Substrates and Products (Substrate)
EC Number |
Substrates |
Comment Substrates |
Organism |
Products |
Comment (Products) |
Rev. |
Reac. |
---|
2.7.11.10 |
ATP + [biotinylated IkappaBa peptide] |
i.e. biotin-Gly-Leu-Lys-Lys-Glu-Arg-Leu-Leu-Asp-Asp-Arg-His-Asp-Ser32-Gly-Leu-Asp-Ser36-Met-Lys-Asp-Glu-Glu |
Homo sapiens |
ADP + [biotinylated IkappaBa phosphopeptide] |
- |
? |
|
2.7.11.10 |
ATP + [IkappaB protein] |
- |
Homo sapiens |
ADP + [IkappaB phosphoprotein] |
- |
? |
|
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
2.7.11.10 |
IkappaB kinase-2 |
- |
Homo sapiens |
2.7.11.10 |
IKK-2 |
- |
Homo sapiens |
Temperature Optimum [°C]
EC Number |
Temperature Optimum [°C] |
Temperature Optimum Maximum [°C] |
Comment |
Organism |
---|
2.7.11.10 |
25 |
- |
assay at |
Homo sapiens |
pH Optimum
EC Number |
pH Optimum Minimum |
pH Optimum Maximum |
Comment |
Organism |
---|
2.7.11.10 |
7.6 |
- |
aassay at |
Homo sapiens |
Cofactor
EC Number |
Cofactor |
Comment |
Organism |
Structure |
---|
2.7.11.10 |
ATP |
- |
Homo sapiens |
|
General Information
EC Number |
General Information |
Comment |
Organism |
---|
2.7.11.10 |
additional information |
homology molecular model of the IKK-2 kinase domain, overview |
Homo sapiens |
2.7.11.10 |
physiological function |
IKK-2 plays a central role in the overall NF-kappaB regulation |
Homo sapiens |